Kendall Capital Management Quest Diagnostics Inc Transaction History

Kendall Capital Management

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 31, 2023	SELL	$121.86 - $144.92 $150,497 - $178,976	-1,235 Reduced 32.46%	2,570 $313,000
Q2 2023 Jul 28, 2023	SELL	$130.56 - $146.84 $169,728 - $190,892	-1,300 Reduced 25.47%	3,805 $535,000
Q1 2023 May 11, 2023	SELL	$131.53 - $155.76 $9,864 - $11,682	-75 Reduced 1.45%	5,105 $722,000
Q4 2022 Jan 30, 2023	SELL	$123.31 - $157.26 $31,444 - $40,101	-255 Reduced 4.69%	5,180 $810,000
Q3 2022 Nov 02, 2022	SELL	$121.77 - $141.1 $14,612 - $16,932	-120 Reduced 2.16%	5,435 $667,000
Q2 2022 Jul 29, 2022	SELL	$127.07 - $145.39 $34,308 - $39,255	-270 Reduced 4.64%	5,555 $739,000
Q1 2022 May 06, 2022	SELL	$129.09 - $164.35 $15,490 - $19,722	-120 Reduced 2.02%	5,825 $797,000
Q4 2021 Jan 28, 2022	BUY	$140.36 - $173.01 $15,439 - $19,031	110 Added 1.89%	5,945 $1.03 Million
Q3 2021 Nov 05, 2021	BUY	$132.95 - $158.0 $237,980 - $282,820	1,790 Added 44.25%	5,835 $848,000
Q2 2021 Jul 30, 2021	BUY	$126.66 - $141.48 $512,339 - $572,286	4,045 New	4,045 $534,000

923

95M

379K

354K

Ticker DGX
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 113,887,000
Market Cap $15.6B
Description
Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers dia...

Get notified when there are updates to the investment portfolio of Kendall Capital Management, based on Form 13F filings with the SEC.

Stay updated on Kendall Capital Management with notifications on news.